Previous studies have demonstrated that atorvastatin can prevent LPS-induced depression-like behavior (Taniguti et al., 2019) and activate autophagy while relieving oxidative stress through acting on NADPH oxidase 2 (NOX2), thereby improving depression-like behavior in mice with Parkinson’s disease (Yan et al., 2020). The gene discussed is CYBB; the disease is depressive disorder.